Stimulation of the Na+-coupled glucose transporter SGLT1 by B-RAF

Biochemical and Biophysical Research Communications

Volumn 427, Issue 4, 2012, Pages 689-693

  Pakladok, Tatsiana ^a   Hosseinzadeh, Zohreh ^a   Alesutan, Ioana ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Energy depletion; Glucose uptake; Tumor cells

Indexed keywords

B RAF KINASE; BREFELDIN A; SODIUM GLUCOSE COTRANSPORTER 1;

ARTICLE; CELL MEMBRANE; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRODE; FEMALE; GLUCOSE TRANSPORT; KINETICS; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VOLTAGE CLAMP; WILD TYPE; XENOPUS;

ANIMALS; BIOLOGICAL TRANSPORT; BREFELDIN A; CELL MEMBRANE; CELLS, CULTURED; GLUCOSE; HUMANS; OOCYTES; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS B-RAF; SODIUM-GLUCOSE TRANSPORTER 1; XENOPUS;

EID: 84868213168     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.062     Document Type: Article

References (42)

1. Nualart F., Los Angeles G.M., Medina R.A., Owen G.I. Glucose transporters in sex steroid hormone related cancer. Curr. Vasc. Pharmacol. 2009, 7:534-548.
2. Thorens B., Mueckler M. Glucose transporters in the 21st century. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E141-E145.
3. Wright E.M., Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004, 447:510-518.
4. Casneuf V.F., Fonteyne P., Van Damme N., Demetter P., Pauwels P., de Hemptinne B., De Vos M., Van de W.C., Peeters M. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. Cancer Invest. 2008, 26:852-859.
5. Engelman J.A., Cantley L.C. A sweet new role for EGFR in cancer. Cancer Cell 2008, 13:375-376.
6. Ganapathy V., Thangaraju M., Prasad P.D. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol. Ther. 2009, 121:29-40.
7. Ishikawa N., Oguri T., Isobe T., Fujitaka K., Kohno N. SGLT gene expression in primary lung cancers and their metastatic lesions. Jpn. J. Cancer Res. 2001, 92:874-879.
8. Kidd M., Modlin I.M., Gustafsson B.I., Drozdov I., Hauso O., Pfragner R. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G260-G272.
9. Macheda M.L., Rogers S., Best J.D. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 2005, 202:654-662.
10. Matosin-Matekalo M., Mesonero J.E., Delezay O., Poiree J.C., Ilundain A.A., Brot-Laroche E. Thyroid hormone regulation of the Na+/glucose cotransporter SGLT1 in Caco-2 cells. Biochem. J. 1998, 334(Pt 3):633-640.
11. Weihua Z., Tsan R., Huang W.C., Wu Q., Chiu C.H., Fidler I.J., Hung M.C. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 2008, 13:385-393.
12. Hosseinzadeh Z., Bhavsar S.K., Shojaiefard M., Saxena A., Merches K., Sopjani M., Alesutan I., Lang F. Stimulation of the glucose carrier SGLT1 by JAK2. Biochem. Biophys. Res. Commun. 2011, 408:208-213.
13. Leiprecht N., Munoz C., Alesutan I., Siraskar G., Sopjani M., Foller M., Stubenrauch F., Iftner T., Lang F. Regulation of Na(+)-coupled glucose carrier SGLT1 by human papillomavirus 18 E6 protein. Biochem. Biophys. Res. Commun. 2010.
14. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2002, 2:342-350.
15. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005, 6:204.
16. Parkin D.M., Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006, 24(Suppl. 3). S3-11-S3-25.
17. Andreadi C., Noble C., Patel B., Jin H., Aguilar Hernandez M.M., Balmanno K., Cook S.J., Pritchard C. Regulation of MEK/ERK pathway output by subcellular localization of B-Raf. Biochem. Soc. Trans. 2012, 40:67-72.
18. Osborne J.K., Zaganjor E., Cobb M.H. Signal control through Raf: in sickness and in health. Cell Res. 2012, 22:14-22.
19. Roskoski R. RAF protein-serine/threonine kinases: structure and regulation. Biochem. Biophys. Res. Commun. 2010, 399:313-317.
20. Roring M., Brummer T. Aberrant B-Raf signaling in human cancer-10 years from bench to bedside. Crit. Rev. Oncog. 2012, 17:97-121.
21. Kamata T., Pritchard C. Mechanisms of aneuploidy induction by RAS and RAF oncogenes. Am. J. Cancer Res. 2011, 1:955-971.
22. De Luca A., Maiello M.R., D'Alessio A., Pergameno M., Normanno N. The RAS/RAF/MEK/ERK and the PI3K/AKT signaling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin. Ther. Targets 2012, 16(Suppl. 2):S17-S27.
23. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A., Nicholson A., Ho J.W., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R., Marshall C.J., Wooster R., Stratton M.R., Futreal P.A. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
24. Eisenhardt A.E., Olbrich H., Roring M., Janzarik W., Anh T.N., Cin H., Remke M., Witt H., Korshunov A., Pfister S.M., Omran H., Brummer T. Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma. Int. J. Cancer 2011, 129:2297-2303.
25. Kim D.H., Sim T. Novel small molecule Raf kinase inhibitors for targeted cancer therapeutics. Arch. Pharm. Res. 2012, 35:605-615.
26. Rusconi P., Caiola E., Broggini M. RAS/RAF/MEK inhibitors in oncology. Curr. Med. Chem. 2012, 19:1164-1176.
27. Santarpia L., Lippman S.M., El Naggar A.K. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin. Ther. Targets 2012, 16:103-119.
28. Suojun Z., Feng W., Dongsheng G., Ting L. Targeting Raf/MEK/ERK pathway in pituitary adenomas. Eur. J. Cancer 2012, 48:389-395.
29. Rexhepaj R., Dermaku-Sopjani M., Gehring E.M., Sopjani M., Kempe D.S., Foller M., Lang F. Stimulation of electrogenic glucose transport by glycogen synthase kinase 3. Cell. Physiol. Biochem. 2010, 26:641-646.
30. Dieter M., Palmada M., Rajamanickam J., Aydin A., Busjahn A., Boehmer C., Luft F.C., Lang F. Regulation of glucose transporter SGLT1 by ubiquitin ligase Nedd4-2 and kinases SGK1, SGK3, and PKB. Obes. Res. 2004, 12:862-870.
31. Mohamed M.R., Alesutan I., Foller M., Sopjani M., Bress A., Baur M., Salama R.H., Bakr M.S., Mohamed M.A., Blin N., Lang F., Pfister M. Functional analysis of a novel I71N mutation in the GJB2 gene among Southern Egyptians causing autosomal recessive hearing loss. Cell. Physiol. Biochem. 2010, 26:959-966.
32. Dermaku-Sopjani M., Sopjani M., Saxena A., Shojaiefard M., Bogatikov E., Alesutan I., Eichenmuller M., Lang F. Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell. Physiol. Biochem. 2011, 28:251-258.
33. Bohmer C., Sopjani M., Klaus F., Lindner R., Laufer J., Jeyaraj S., Lang F., Palmada M. The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cell. Physiol. Biochem. 2010, 25:723-732.
34. Strutz-Seebohm N., Pusch M., Wolf S., Stoll R., Tapken D., Gerwert K., Attali B., Seebohm G. Structural basis of slow activation gating in the cardiac I Ks channel complex. Cell. Physiol. Biochem. 2011, 27:443-452.
35. Alesutan I.S., Ureche O.N., Laufer J., Klaus F., Zurn A., Lindner R., Strutz-Seebohm N., Tavare J.M., Boehmer C., Palmada M., Lang U.E., Seebohm G., Lang F. Regulation of the glutamate transporter EAAT4 by PIKfyve. Cell. Physiol. Biochem. 2010, 25:187-194.
36. Hosseinzadeh Z., Bhavsar S.K., Sopjani M., Alesutan I., Saxena A., Dermaku-Sopjani M., Lang F. Regulation of the glutamate transporters by JAK2. Cell. Physiol. Biochem. 2011, 28:693-702.
37. Hirsch J.R., Loo D.D., Wright E.M. Regulation of Na+/glucose cotransporter expression by protein kinases in Xenopus laevis oocytes. J. Biol. Chem. 1996, 271:14740-14746.
38. Subramanian S., Glitz P., Kipp H., Kinne R.K., Castaneda F. Protein kinase-A affects sorting and conformation of the sodium-dependent glucose co-transporter SGLT1. J. Cell. Biochem. 2009, 106:444-452.
39. Sopjani M., Bhavsar S.K., Fraser S., Kemp B.E., Foller M., Lang F. Regulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase. Mol. Membr. Biol. 2010, 27:137-144.
40. Mendez L.E., Manci N., Cantuaria G., Gomez-Marin O., Penalver M., Braunschweiger P., Nadji M. Expression of glucose transporter-1 in cervical cancer and its precursors. Gynecol. Oncol. 2002, 86:138-143.
41. Rudlowski C., Becker A.J., Schroder W., Rath W., Buttner R., Moser M. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer. Am. J. Clin. Pathol. 2003, 120:691-698.
42. Lang F., Busch G.L., Ritter M., Volkl H., Waldegger S., Gulbins E., Haussinger D. Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 1998, 78:247-306.